Anavex Life Sciences
AVXL
#7720
Rank
C$0.49 B
Marketcap
C$5.53
Share price
-2.19%
Change (1 day)
-57.64%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): C-$0.80

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is C-$0.78. In 2024 the company made an earnings per share (EPS) of C-$0.72 an increase over its 2023 EPS that were of C-$0.83.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.8011.38%
2024C-$0.72-13.33%
2023C-$0.83-3.23%
2022C-$0.8514.81%
2021C-$0.7420%
2020C-$0.62-16.67%
2019C-$0.7438.46%
2018C-$0.5418.18%
2017C-$0.45-21.43%
2016C-$0.58-35.38%
2015C-$0.89-36.27%
2014C-$1.40112.5%
2013C-$0.66-58.62%
2012C-$1.60-0%
2011C-$1.60-29.27%
2010C-$2.2651.85%
2009C-$1.49-0%
2008C-$1.49237.5%
2007C-$0.44
2006N/A-100%
2005C-$0.05505499.97%
2004C-$0.009175

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
C$3.29-519.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C-$0.06881-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$1.38-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C-$83.95 10,601.75%๐Ÿ‡บ๐Ÿ‡ธ USA